Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.1868 | 48 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.91588 | 40 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.18092 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.23897 | 53 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.23622 | 53 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.21297 | 47 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.59164 | 58 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.18069 | 50 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.60052 | 60 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.14638 | 49 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.1003 | 47 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.18017 | 51 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.71824 | 62 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.10491 | 47 |